Perbedaan Teknologi Karya Digital Nusa Tbk. dan Tempo Scan Pacific Tbk.: Teknologi Karya Digital Nusa Tbk. diperdagangkan di Rp114 (kapitalisasi pasar 392,53 M, volume 24 jam 111,22 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.610 (kapitalisasi pasar 11,64 T, volume 24 jam 278,4 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 29,7× kapitalisasi pasar Teknologi Karya Digital Nusa Tbk., dan Teknologi Karya Digital Nusa Tbk. lebih aktif diperdagangkan (111,22 jt vs 278,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| TRON | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 392,53 M | 11,64 T |
Volume | 111,22 jt | 278,4 rb |
Lot | 1,11 jt | 2,78 rb |
Perputaran | 13,33 M | 723,93 jt |
Harga Rata-rata | 119,86 | 2.600,31 |
Nilai Transaksi | 13,33 M | 723,93 jt |
Harga Ekuilibrium Indikatif | 114 | 2.610 |
Volume Ekuilibrium Indikatif | 3,28 rb | 74 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Teknologi Karya Digital Nusa Tbk (formerly PT Damai Harapan Sentosa) (the Entity) wasestablished based on Notarial Deed No. 25 dated January 7, 2011 of Tjoa Karina Juwita SH., Notaryin Jakarta. The Entity started its commercial operations in 2015. PT Teknologi Karya Digital Nusa Tbk is the parent entity, whereas David Santoso is the ultimate beneficial owner starting from 2020.
Selengkapnya di halaman TRON →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →